Bumble Inc vs Novartis AG — how do they compare? Bumble Inc trades at $2.82 (market cap $366.87M), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 805.1× Bumble Inc's market cap, and Novartis AG pays a 3.07% dividend while Bumble Inc pays none. Which is the better fit depends on your goals.
| BMBL | NVS | |
|---|---|---|
Market Cap | $366.87M | $295.37B |
Sector | Technology | Health |
52-Week High | $7.17 | $168.62 |
52-Week Low | $2.70 | $119.31 |
Enterprise Value | $672.73M | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →